Testing effectiveness (Phase 2)UnknownNCT04284228
What this trial is testing
Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT
Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
NexImmune Inc. 22